{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+Furoate%2FVilanterol&page=2", "query": { "intervention": "Fluticasone Furoate/Vilanterol", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 43, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+Furoate%2FVilanterol&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+Furoate%2FVilanterol&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-07T03:10:57.180Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05757102", "title": "A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FF/UMEC/VI", "type": "DRUG" }, { "name": "ELLIPTA", "type": "DEVICE" }, { "name": "FF/VI", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 138, "start_date": "2023-04-24", "completion_date": "2027-01-28", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-07T03:10:57.180Z", "location_count": 28, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Paradise Valley, Arizona + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05757102" }, { "nct_id": "NCT03949842", "title": "Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists", "type": "DRUG" }, { "name": "Fluticasone furoate/umeclidinium/vilanterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 0, "start_date": "2019-06-27", "completion_date": "2022-11-30", "has_results": false, "last_update_posted_date": "2020-04-22", "last_synced_at": "2026-10-07T03:10:57.180Z", "location_count": 3, "location_summary": "Waterbury, Connecticut • Charlotte, North Carolina • Layton, Utah", "locations": [ { "city": "Waterbury", "state": "Connecticut" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Layton", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03949842" }, { "nct_id": "NCT03478696", "title": "A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "budesonide/formoterol", "type": "DRUG" }, { "name": "albuterol/salbutamol", "type": "DRUG" }, { "name": "FF/UMEC/VI", "type": "DRUG" }, { "name": "Placebo to match budesonide/formoterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "Placebo to match FF/UMEC/VI", "type": "DRUG" }, { "name": "placebo to match tiotropium", "type": "DRUG" }, { "name": "ELLIPTA", "type": "DEVICE" }, { "name": "MDI", "type": "DEVICE" }, { "name": "HandiHaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 732, "start_date": "2018-06-25", "completion_date": "2019-03-18", "has_results": true, "last_update_posted_date": "2020-10-28", "last_synced_at": "2026-10-07T03:10:57.180Z", "location_count": 42, "location_summary": "Mobile, Alabama • Bakersfield, California • Sacramento, California + 35 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Bakersfield", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Westminster", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03478696" }, { "nct_id": "NCT02924688", "title": "A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FF/UMEC/VI (100/31.25/25) mcg", "type": "DRUG" }, { "name": "FF/UMEC/VI (100/62.5/25) mcg", "type": "DRUG" }, { "name": "FF/UMEC/VI (200/31.25/25) mcg", "type": "DRUG" }, { "name": "FF/UMEC/VI (200/62.5/25) mcg", "type": "DRUG" }, { "name": "FF/VI (100/25) mcg", "type": "DRUG" }, { "name": "FF/VI (200/25) mcg", "type": "DRUG" }, { "name": "Fluticasone/salmeterol (FSC)", "type": "DRUG" }, { "name": "Albuterol/salbutamol", "type": "DRUG" }, { "name": "ELLIPTA DPI", "type": "DEVICE" }, { "name": "DISKUS DPI", "type": "DEVICE" }, { "name": "METERED-DOSE INHALER (MDI)", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2436, "start_date": "2016-10-13", "completion_date": "2019-02-22", "has_results": true, "last_update_posted_date": "2021-03-26", "last_synced_at": "2026-10-07T03:10:57.180Z", "location_count": 99, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 89 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02924688" }, { "nct_id": "NCT04072887", "title": "Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "QBW251", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "COPD maintenance background therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 974, "start_date": "2019-09-12", "completion_date": "2022-02-01", "has_results": true, "last_update_posted_date": "2023-04-28", "last_synced_at": "2026-10-07T03:10:57.180Z", "location_count": 25, "location_summary": "Andalusia, Alabama • Los Angeles, California • Westminster, California + 22 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Westminster", "state": "California" }, { "city": "Ormond Beach", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04072887" }, { "nct_id": "NCT01165138", "title": "Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone furoate/Vilanterol Inhalation Powder", "type": "DRUG" }, { "name": "Fluticasone Furoate Inhalation Powder", "type": "DRUG" }, { "name": "Placebo Inhaltion Powder", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 612, "start_date": "2010-08-20", "completion_date": "2011-10-19", "has_results": true, "last_update_posted_date": "2018-02-14", "last_synced_at": "2026-10-07T03:10:57.180Z", "location_count": 24, "location_summary": "Bell Gardens, California • Huntington Beach, California • Long Beach, California + 19 more", "locations": [ { "city": "Bell Gardens", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01165138" }, { "nct_id": "NCT01316900", "title": "24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "GSK573719/GW642444 125/25", "type": "DRUG" }, { "name": "GSK573719/GW642444 62.5/25", "type": "DRUG" }, { "name": "GW642444", "type": "DRUG" }, { "name": "tiotropium bromide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 846, "start_date": "2011-03-01", "completion_date": "2012-04-24", "has_results": true, "last_update_posted_date": "2018-01-24", "last_synced_at": "2026-10-07T03:10:57.180Z", "location_count": 19, "location_summary": "Birmingham, Alabama • San Diego, California • DeLand, Florida + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01316900" }, { "nct_id": "NCT02164513", "title": "A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "fluticasone furoate (FF)", "type": "DRUG" }, { "name": "vilanterol (VI)", "type": "DRUG" }, { "name": "umeclidinium bromide (UMEC)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 10355, "start_date": "2014-06-30", "completion_date": "2017-07-17", "has_results": true, "last_update_posted_date": "2018-10-10", "last_synced_at": "2026-10-07T03:10:57.180Z", "location_count": 269, "location_summary": "Athens, Alabama • Birmingham, Alabama • Florence, Alabama + 226 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Florence", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT02164513" }, { "nct_id": "NCT07282886", "title": "VENTURI (VENTilation Using Respiratory Imaging)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrrolate pMDI", "type": "DRUG" }, { "name": "Fluticasone Furoate/Umeclidinium/Vilanterol 100 MCG/1 ACTUATION-62.5 MCG/1 ACTUATION-25 MCG/1 ACTUATION Inhalation Powder", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 20, "start_date": "2026-03-15", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-10-07T03:10:57.180Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07282886" }, { "nct_id": "NCT06372496", "title": "Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate", "type": "DRUG" }, { "name": "Inhaled corticosteroids/long-acting beta-2 agonists", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1358, "start_date": "2024-04-16", "completion_date": "2027-06-14", "has_results": true, "last_update_posted_date": "2026-10-06", "last_synced_at": "2026-10-07T03:10:57.180Z", "location_count": 36, "location_summary": "Centreville, Alabama • Little Rock, Arkansas • Newport Beach, California + 31 more", "locations": [ { "city": "Centreville", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Newport Beach", "state": "California" }, { "city": "Newark", "state": "Delaware" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06372496" } ] }